STSA 13D/13G Filings - Satsuma Pharmaceuticals Inc.

Real time Form 13D and 13G transaction reports:

Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
Shares have beem adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Goto Prev, 0, 1

Reported DateTime	Transaction Date	Type	Company Symbol	Filed By Symbol	Shares Owned % Owned	Shares Vs. Prev Report	View
2021-03-15 07:57 am Purchase	2021-03-03	13G	Satsuma Pharmaceuticals, Inc. STSA	Commodore Capital LP	2,119,245 6.700%	2,119,245 (New Position)	Filing History
2021-03-02 4:32 pm Purchase	2009-02-28	13D	Satsuma Pharmaceuticals, Inc. STSA	RA Capital Management, L.P.	5,914,252 18.800%	1,232,394 (+26.32%)	Filing History
2021-02-16 4:30 pm Sale	2020-12-31	13G	Satsuma Pharmaceuticals, Inc. STSA	Citadel Advisors LLC	364,785 2.100%	-652,697 (-64.15%)	Filing History
2021-02-12 3:59 pm Purchase	2020-12-31	13G	Satsuma Pharmaceuticals, Inc. STSA	MORGAN STANLEY MS	993,623 5.700%	112,185 (+12.73%)	Filing History
2020-12-18 4:27 pm Purchase	2020-12-11	13G	Satsuma Pharmaceuticals, Inc. STSA	MORGAN STANLEY MS	881,438 5.100%	881,438 (New Position)	Filing History
2020-12-04 5:12 pm Sale	2020-09-11	13G	Satsuma Pharmaceuticals, Inc. STSA	Osage University Partners III LP	0 0.000%	-935,058 (Position Closed)	Filing History
2020-10-09 1:53 pm Sale	2020-09-30	13G	Satsuma Pharmaceuticals, Inc. STSA	WELLINGTON MANAGEMENT CO LLP	0 0.000%	-1,343,168 (Position Closed)	Filing History
2020-08-10 09:43 am Sale	2020-07-31	13G	Satsuma Pharmaceuticals, Inc. STSA	WELLINGTON MANAGEMENT CO LLP	1,343,168 7.720%	-998,043 (-42.63%)	Filing History

Goto Prev, 0, 1